Carnot OPALE

The OPALE Carnot Institute is a preferred partner to the healthcare Industry for research and development of innovative solutions aimed at diagnostic, treatment and follow-up of patients with leukemia and related diseases, together the blood cancer with the highest mortality rate, also the first child cancer. Thanks to its 550 engaged staff, the Institute offers partner companies an easy, quick and efficient access to internationally unmatched R&D expertise and specialized means for the acceleration, together, of innovation along the R&D value chain.